NMOSD-like lesions, including AQP4 expression loss, astrocytic swelling, perivascular complement deposition, and granulocytic infiltration, were observed after NMO-IgG was injected with human (but not mouse) complement (25). Here, AQP4 is linked to neuromyelitis optica.